{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:09:23Z","timestamp":1791223763002,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/fpc.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:28:15Z","timestamp":1404865695000},"page":"527-529","source":"Crossref","is-referenced-by-count":7,"title":["Recipient\/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant"],"prefix":"10.1097","volume":"24","author":[{"given":"Cindy","family":"Serdjebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ciccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Fina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnauld","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lacarelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u2019Houcine","family":"Ouafik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210213","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2009.24.4491","article-title":". Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies.","volume":"28","author":"Ciccolini","year":"2010","journal-title":"J Clin Oncol"},{"key":"R2-7-20210213","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/pgs.11.175","article-title":". CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.","volume":"13","author":"Ciccolini","year":"2012","journal-title":"Pharmacogenomics"},{"key":"R3-7-20210213","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/pgs.12.208","article-title":"Severe or lethal toxicities with nucleosidic analogs: time for action.","volume":"14","author":"Evrard","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.trim.2012.12.002","article-title":"Frequent hepatocyte chimerism in long-term human liver allografts independent of graft outcome.","volume":"28","author":"Aini","year":"2013","journal-title":"Transpl Immunol"},{"key":"R5-7-20210213","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.TP.0000144055.78462.4F","article-title":". Recipient-derived hepatocytes in sex-mismatched liver allografts after liver transplantation: early versus late transplant biopsies.","volume":"78","author":"Idilman","year":"2004","journal-title":"Transplantation"},{"key":"R6-7-20210213","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4161\/chim.2.4.19177","article-title":"Host stem cells repopulate liver allografts: reverse chimerism.","volume":"2","author":"Sun","year":"2011","journal-title":"Chimerism"},{"key":"R7-7-20210213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bpg.2009.02.011","article-title":"Pharmacogenetics in chemotherapy of colorectal cancer.","volume":"23","author":"Henriette Tanja","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3322\/caac.20002","article-title":"Pharmacogenetics and pharmacogenomics of anticancer agents.","volume":"59","author":"Huang","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2766","article-title":"Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.","volume":"223","author":"Lee","year":"2011","journal-title":"J Pathol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:22:13Z","timestamp":1620951733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201410000-00007"}},"subtitle":["A deadly gift?"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000076","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}